Oligometastatic Prostate Cancer (OMPC)
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Oligometastatic Prostate Cancer (OMPC)?
There are 2 clinical trials targeting Oligometastatic Prostate Cancer (OMPC) tracked by BioSniper.
What is the prevalence of Oligometastatic Prostate Cancer (OMPC)?
The estimated prevalence of Oligometastatic Prostate Cancer (OMPC) is approximately 256.0 per 100,000 population.
Deep-dive into Oligometastatic Prostate Cancer (OMPC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis